Population increase, according to David Packard, creator of Hewlett-Packard, might one day produce “total calamity for humanity.” Even though the foundation is not legally obligated to follow his policy preferences, they have embraced his beliefs and sought liberal action. According to an examination of their financial filings, they have spent roughly $350 million on extending abortion access only in the previous five years.
The Packard Foundation has invested millions of dollars in anti-natalist organizations and businesses. The foundation was a crucial player in the deregulation battle that resulted in the FDA making it easier to obtain an abortion medication. One of the biggest winners is GenBioPro, the sole firm that manufactures a generic version of the abortion medication.
In 2017, the Packard Foundation donated $1 million to the Reproductive Freedom Project. It increased its investment in GenBioPro to $1.5 million in 2019, the same year the FDA approved its generic abortion pill. The business manufactures mifepristone, an oral medication used to induce abortion.
The Packard Foundation has donated millions of dollars to a group that promotes the deregulation of abortion pills and increases access to over-the-counter abortion medications. The foundation’s dark money arm provided more than $3.7 million in “reproductive health” awards from 2017 to 2021. The foundation designated $1 million of the donation to All Above All, a nonprofit that has lobbied for the deregulation of abortion pills.
Moreover, Mifeprex was brought to market with the support of the Packard Foundation, which provided a $14 million loan to its producer, Danco Laboratories, in 1996. The ACLU filed a lawsuit against the FDA in May 2020, challenging the agency’s abortion medication limitations. The FDA stated in December that it would remove all limits on abortion pills, enabling them to be prescribed online and delivered via mail.
The Packard Foundation financed GenBioPro, which oversaw the deregulation of abortion pills. The foundation did not respond to whether it stands to earn if its worth rises. Proponents of the abortion pill quickly pointed out that their struggle is far from done. “Other hurdles exist, and they must be removed once and for all,” said Destiny Lopez, co-president of All Above All.